MOGAM BIOTECHNOLOGY RESEARCH INSTITUTE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 14153
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 11244
 
  
 
C07K PEPTIDES 5131
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0145,107 EPITOPES OF EPIDERMAL GROWTH FACTOR RECEPTOR SURFACE ANTIGENAND USE THEREOFFeb 06, 17May 25, 17[A61K, C12N, C07K]
2015/0231,220 EPITOPES OF EPIDERMAL GROWTH FACTOR RECEPTOR SURFACE ANTIGEN AND USE THEREOFMar 27, 13Aug 20, 15[A61K, G01N, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9834753 Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the sameDec 18, 12Dec 05, 17[A61K, C12N]
9493745 Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the sameOct 23, 14Nov 15, 16[A61K, C12N, A61P, C07K]
9018182 Tumor specific promoter and oncolytic virus vector comprising the sameApr 26, 10Apr 28, 15[A61K, C12N]
8841426 Mutant of granulocyte-colony stimulating factor (G-CSF) and chemically conjugated polypeptide thereofJul 19, 06Sep 23, 14[A61K, C07K]
8715696 Full genome DNA of human cytomegalovirus strain JHC isolated from Korean patient and open reading frames thereofNov 29, 11May 06, 14[A61K, A01N, C12N]
8685409 Influenza T-cell immunization against diverse influenza A virusesNov 01, 12Apr 01, 14[A61K]
8628956 Expression vector suitable for expression of a coding sequence for gene therapyMar 19, 12Jan 14, 14[C07H, C12N]
8617875 Expression vector suitable for expression of a coding sequence for gene therapyMar 19, 12Dec 31, 13[C07H, C12N]
8569051 Expression vector for gene therapyMar 19, 12Oct 29, 13[C07H, C12N]
8318199 Liposome for liver-specific delivery and release of therapeutic nucleic acids or drugsJun 01, 10Nov 27, 12[A61K, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0147,458 NOVEL VARICELLA-ZOSTER VIRUS STRAINS, AND CHICKEN POX AND HERPES ZOSTER VIRUS VACCINE USING SAMEAbandonedFeb 24, 12May 29, 14[C07K]
2013/0058,897 HEXON ISOLATED FROM SIMIAN ADENOVIRUS SEROTYPE 19, HYPERVARIABLE REGION THEREOF AND CHIMERIC ADENOVIRUS USING THE SAMEAbandonedApr 14, 10Mar 07, 13[A61K, C12N, A61P, C07K]
2011/0129,872 METHOD FOR A PRODUCTION OF A RECOMBINANT PROTEIN USING YEAST CO-EXPRESSION SYSTEMAbandonedDec 01, 09Jun 02, 11[C12P]
2011/0008,885 LINEAR DOUBLE-STRANDED RNA MOLECULE INTERFERING WITH DIFFERENT TARGET GENESAbandonedJul 07, 08Jan 13, 11[C07H, C12N]
2010/0256,073 THERAPEUTIC AGENT COMPRISING LIPOCALIN 2 AGAINST CANCER METASTASIS, AND METHODS OF EARLY DIAGNOSIS AND INHIBITION OF CANCER METASTASIS USING LIPOCALIN 2AbandonedMay 13, 10Oct 07, 10[A61K, A61P]
2010/0209,491 METHOD FOR ENHANCING SERUM STABILITY AND LOWERING IMMUNE RESPONSE OF SIRNA DOWN-REGULATING GENE EXPRESSION OF HBV OR HCVAbandonedMay 08, 08Aug 19, 10[A61K, C07H, A61P]
2010/0196,370 FUSION PROTEIN OF IMMUNOGLOBULIN FC AND HUMAN APOLIPOPROTEIN(A) KRINGLE FRAGMENTAbandonedNov 16, 07Aug 05, 10[A61K, C07H, C12P, C12N, A61P, C07K]
2010/0063,132 SMALL INTERFERING RNA AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HEPATITIS B COMPRISING THE SAMEAbandonedAug 20, 09Mar 11, 10[A61K, C07H, C12N, A61P]
2010/0003,742 METHOD FOR REDUCING FUCOSE CONTENTS OF RECOMBINANT PROTEINSAbandonedJan 09, 09Jan 07, 10[C07K]
2009/0318,531 Small Interfering RNA Specific For HCV And Therapeutic Agent For Hepatitis C Comprising The SameAbandonedMay 30, 06Dec 24, 09[A61K, C07H, C12N]
2009/0311,224 THERAPEUTIC AGENT COMPRISING LIPOCALIN 2 AGAINST CANCER METASTASIS, AND METHODS OF EARLY DIAGNOSIS AND INHIBITION OF CANCER METASTASIS USING LIPOCALIN 2AbandonedFeb 24, 06Dec 17, 09[A61K, C07H, C12Q, C12N, A61P, C07K]
2009/0305,965 Stabilized Parathyroid Hormone Composition Comprising Parathyroid Hormone, Buffer and Stabilizing AgentAbandonedJun 05, 06Dec 10, 09[A61K, A61P]
2008/0138,394 Composite For Liver-Specific Delivery and Release of Therapeutic Nucleic Acids or DrugsAbandonedApr 27, 07Jun 12, 08[A61K]
2008/0112,977 Supertype Epitopes, Oligonucleotides Coding The Same Which Induce Effective Ctl Response Against Hcv And The Use ThereofAbandonedJul 04, 05May 15, 08[A61K, C07H, C12N, A61P]
2008/0096,839 Small Interfering Rna and Pharmaceutical Composition for Treatment of Hepatitis B Comprising the SameAbandonedMar 09, 06Apr 24, 08[A61K, C07H, C12N, A61P]
7285277 Anticancer agentExpiredSep 23, 05Oct 23, 07[A61K]
2007/0031,379 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the sameAbandonedJan 10, 05Feb 08, 07[A61K]
6743428 Angiogenesis inhibitorExpiredMar 15, 02Jun 01, 04[A61K, A67K]
2004/0082,664 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical compositionAbandonedApr 11, 03Apr 29, 04[A61K]
6692735 Variant of C6 .beta.-chemokine leukotactin-1(shLkn-1) with enhanced biological activityExpiredJul 21, 99Feb 17, 04[C12N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.